The Adenosine Triphosphate (ATP) Swab Test Market size was estimated to be US$ 229.33 million in 2021 and US$ XX million in 2023 and is expected to reach US$ 535.16 million by 2031; it is estimated to record a CAGR of 9.2% in till 2031. Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System is likely to remain key Adenosine Triphosphate (ATP) Swab Test Market trends.
Rising prevalence of Healthcare-Associated Infections (HAIs) is one of the prominent factors, which is driving the demand for Adenosine Triphosphate (ATP) Swab Test. For instance, the World Health Organization (WHO), launched the first-ever global report on Infection Prevention and Control in May 2022. The report states that out of every 100 patients admitted to acute-care hospitals, 7 patients in high-income countries and 15 patients in low- and middle-income countries are at risk of acquiring at least one HAIs during their hospital stay. On average, 1 in every ten affected patients will die from their HAIs. Such substantial prevalence of HAIs is anticipated to have a positive impact on the adoption of ATP swab test driving the growth of Adenosine Triphosphate (ATP) Swab Test market.
The growth of the Adenosine Triphosphate (ATP) Swab Test market is attributed to some key driving factors such as rising prevalence of HAIs and increasing emphasis on food safety. However, limitations of ATP swab tests is a major factor hindering the market growth. Global Adenosine Triphosphate (ATP) swab test market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the US is the largest market for ATP swab tests. The growth of the region is attributed to presence of key market players and rising prevalence of HAIs. In addition, continuous product developments is further expected to stimulate the growth of Adenosine Triphosphate (ATP) swab test market in North America.
The Asia Pacific region is expected to account for the fastest growth in the Adenosine Triphosphate (ATP) swab test market. The rapid growth in the healthcare and food & beverage industry and increased investments and innovations in the hygiene monitoring system by major market players in Asia Pacific for their geographical expansion and other strategies is likely to fuel the growth of the market.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Adenosine Triphosphate (ATP) Swab Test Market: Strategic Insights
According to the WHO, unsafe food is responsible for causing 600 million cases of foodborne diseases and 420,000 deaths every year globally. Children under five years of age account for 30% of these deaths. Furthermore, WHO estimates that globally, 33 million years of healthy lives are lost annually due to consuming unsafe food, and this number is likely an underestimation. Consuming food contaminated with bacteria, viruses, parasites, or chemical substances like heavy metals can cause over 200 different diseases, contributing significantly to disease burden and mortality worldwide. ATP testing is especially crucial in food production environments. If food isn't cleaned up correctly, it can promote the growth of microbes. Food can also serve as a source of nutrients for bacteria, mould, and yeast, which can lead to their growth. Therefore, ATP testing can be used to provide an early warning system and to ensure that food environments are appropriately hygienic. Such substantial prevalence of foodborne diseases and conditions is boosting the need for food safety. This need is likely to drive the ATP swab test market during the forecast period
HAIs are one of the prominent causes for substantial mortality and illness amongst hospital patients. In addition, these conditions lead to additional financial and emotional burden on patients as well as healthcare systems across the globe. Therefore, the government and healthcare authorities are emphasizing on implementation of safety programs to prevent healthcare-associated infections. For instance, In 2019, the Seventy-second World Health Assembly passed a resolution (WHA72.6) on “Global action on patient safety”, mandating the development of a global patient safety action plan. The Global Patient Safety Action Plan for the decade 2021-2030 provides a comprehensive framework for stakeholders to join efforts and implement patient safety initiatives in a coordinated manner. Implementation of such policies are estimated to generate attractive growth opportunity for the Adenosine Triphosphate (ATP) swab test market.
Key segments that contributed to the derivation of the Adenosine Triphosphate (ATP) Swab Test Market analysis are type, and application.
The geographic scope of the Adenosine Triphosphate (ATP) Swab Test Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the Adenosine Triphosphate (ATP) Swab Test Market. The Centers for Disease Control (CDC) estimates that in American hospitals, HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year. The growth in North America is characterized by the growing burden of HAIs is expected to boost Adenosine Triphosphate (ATP) Swab Test Market demand. Similarly, increasing incidence of foodborne diseases and food contamination are equally influencing the market's growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Adenosine Triphosphate (ATP) Swab Test Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Adenosine Triphosphate (ATP) Swab Test Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 229.33 Million |
| Market Size by 2031 | US$ 535.16 Million |
| Global CAGR (2023 - 2031) | 9.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Adenosine Triphosphate (ATP) Swab Test Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Adenosine Triphosphate (ATP) Swab Test Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Adenosine Triphosphate (ATP) Swab Test Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Adenosine Triphosphate (ATP) Swab Test and strategies:
The “Adenosine Triphosphate (ATP) Swab Test Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: